XML 110 R27.htm IDEA: XBRL DOCUMENT v3.25.2
RESTATEMENT OF FINANCIAL STATEMENTS (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Changes and Error Corrections [Abstract]  
Schedule of restated financial information
Schedule of restated financial information  Impact of correction of error 
Six months ended June 30, 2024 (Unaudited)  As previously reported   Adjustments   As restated 
             
Net cash used in operating activities of continuing operations  $(1,980,727)  $845,427   $(1,135,300)
Net cash provided by financing activities of continuing operations  $4,199,267   $(845,427)  $3,353,840 

 

The Company previously restated its financial statements for the three and six months ended June 30, 2024 via Form 10-Q/A, filed October 17, 2024, as a result of a change in classification of credit loss expense to net revenue. During the original preparation of the financial statements for the three and six months ended June 30, 2024, the Company identified and corrected its accounting for its credit loss expense of $859,321 and $1,199,155, respectively, which was reclassified to net revenue as variable consideration accounted for under ASC 606.

 

The following table summarizes the impact of the correction on the Company’s condensed consolidated statement of operations for the three and six months ended June 30, 2024. This adjustment had no effect on the Company’s condensed consolidated balance sheet, reported loss from operations, net loss, or cash used in operating activities for the periods adjusted. There have been no further corrections from the amended Form 10-Q/A as filed on October 17, 2024.

 

Balance sheet

             
   Impact of correction of error 
June 30, 2024 (Unaudited)  As previously reported   Adjustments   As restated in Form 10-Q/A 
             
Total assets  $24,659,020   $42,862   $24,701,882 
                
Total stockholders’ equity  $5,837,412   $42,862   $5,880,274 

 

Statement of operations

   Impact of correction of error 
Three months ended June 30, 2024 (Unaudited)  As previously reported   Adjustments   As restated in Form 10-Q/A 
             
Revenue  $2,330,964   $(859,321)  $1,471,643 
Cost of sales   793,010        793,010 
Gross profit   1,537,954    (859,321)   678,633 
Operating expense   1,740,299    (902,183)   838,116 
Loss from operations  $(202,345)  $42,862   $(159,483)
Other income, net   27,898        27,898 
Net loss for the period  $(174,447)  $42,862   $(131,585)
Preferred stock dividends  $(326,174)  $   $(326,174)
Net loss attributable to common shareholders  $(500,621)  $42,862   $(457,759)

 

   Impact of correction of error 
Six months ended June 30, 2024 (Unaudited)  As previously reported   Adjustments   As restated in Form 10-Q/A 
             
Revenue  $4,992,930   $(1,199,155)  $3,793,775 
Cost of sales   1,741,164        1,741,164 
Gross profit   3,251,766    (1,199,155)   2,052,611 
Operating expense   3,235,119    (1,242,017)   1,993,102 
Loss from operations  $16,647   $42,862   $59,509 
Other income, net   (362,886)       (362,886)
Net loss before discontinued operations   (346,239)   42,862    (303,377)
Loss from discontinued operations   (111,312)       (111,312)
Net loss for the period  $(457,551)  $42,862   $(414,689)
Preferred stock dividends  $(477,808)  $   $(477,808)
Net loss attributable to common shareholders  $(935,359)  $42,862   $(892,497)